Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2006-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f22544ec1cfd67684f9ee1f7aadcb870 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192b203563abe67a9ed84666994268df |
publicationDate |
2009-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009197774-A1 |
titleOfInvention |
Method for diagnosing thromboembolic disorders and coronary heart disease |
abstract |
The present invention refers to a method for the in vitro diagnosis of thromboembolic and/or coronary heart diseases, wherein the nucleotide at position 470 of a nucleic acid coding for the human EGLN2 protein or the amino acid at position 58 of the human EGLN2 protein of a sample of a person is determined. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9803243-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012009547-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9410204-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10047396-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136626-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10017821-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11421276-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196690-B2 |
priorityDate |
2005-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |